📖+10 XP
🎧+10 XP
✅+15 XP
Level A1 – BeginnerCEFR A1
2 min
76 words
- Butantan-DV is a dengue vaccine made in Brazil.
- Anvisa approved it on 26 November.
- It is for people aged 12 to 59 years.
- The vaccine needs only one dose to work.
- One dose can help reach remote Amazon communities.
- Trials in Brazil had 16,000 volunteers over nearly a decade.
- The vaccine showed 74.7% overall and 91.6% severe efficacy.
- More than 1,000,000 doses are ready for distribution.
- It will join the national programme in early 2026.
Difficult words
- vaccine — medicine that helps the body avoid disease
- approved — to say yes to a new medicine
- dose — small amount of medicine for one timedoses
- remote — far away from towns and cities
- Trials — study to test a medicine or vaccine
- volunteers — person who joins a study by choice
- efficacy — how well a medicine or vaccine works
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you take a vaccine that needs one dose?
- Have you visited a remote area?
Related articles
26 Dec 2025
14 May 2026
Hantavirus linked to international cruise ship
WHO reports 11 hantavirus cases, including three deaths, connected to the Dutch-flagged MV Hondius that sailed from Argentina to Cape Verde. Some passengers later travelled through South Africa; health authorities say public risk remains low.
28 Dec 2025
2 Feb 2026
8 May 2026